Li Auto's March 2026 delivery report represents a genuine sequential recovery and provides near-term relief, but it does not resolve the company's structural challenges: margin pressure, a technical downtrend, and dependence on the upcoming L9 launch as a rerating event. UBS's target price cut to USD 23 from USD 30 reflects a sober reassessment of EREV segment difficulty. The $1 billion buyback signals balance sheet confidence but also reveals that management is prioritizing short-term shareholder support over a period of uncertain fundamentals. The MindVLA autonomous driving disclosure adds long-term optionality but lacks substantive near-term operational impact. Investors should treat this as a modest operational improvement within a still-challenging competitive and margin environment, not as a confirmed inflection point.